Gulf News

المملكة: Through clinical record and financing.. "Health Research” builds an integrated system for innovation


The new organization of the National Institute for Health Research opened broad strategic horizons for developing the research and innovation system in The Saudi health sector, giving the institute expanded powers to finance and manage translational research and clinical trials, and to build A supportive legislative and investment environment.

This move comes within the framework of national plans to enhance the Kingdom’s research capabilities, in line with the goals of Vision 2030 to build A knowledge-based economy, transforming scientific outputs into products and services that contribute to improving the quality of life.

Clinical trials

According to information obtained by “Al-Youm,” the new organization will enable the institute to establish the “Saudi Clinical Trials Register,” which is a national database to document and follow up on all clinical studies carried out in the Kingdom, in a way that ensures transparency and enhances confidence in Its results.

The organization will grant the institute precise powers to determine priorities and programs for research, development and innovation in the field of translational research and clinical trials, and propose standards regulating the appropriate environment for conducting them and submit them to the competent authorities for approval.

Financial sustainability

To ensure financial sustainability, the organization sets clear frameworks for proposing aspects And mechanisms for investing in high-feasibility research, locally and internationally, by financing it and supporting its capabilities, which will encourage the entry of the private sector and investors as partners in supporting health research.

The organization also focuses extensively on developing human resources, as the institute will propose strategic plans to build capabilities and attract distinguished talents, in addition to establishing specialized training programs and developing guides. Guidance for developing national competencies in this vital field.

The National Institute for Health Research, by regulation, is the body responsible for supervising, supporting and financing translational research and clinical trials in the Kingdom. This includes setting procedural rules for financing research, evaluating it, and ensuring its compliance with ethical and professional standards.

The role of the Institute will not stop at supervision, but will extend to developing clear mechanisms to benefit from research results and transform them into tangible health and economic benefits.

At the international level, the Institute will work to strengthen research partnerships. With international organizations and bodies, and representing the Kingdom in relevant bodies.

The organization will work to enable benefiting from existing research infrastructure and facilitate access to it, and enhance integration between research centers, hospitals and universities, in addition to establishing and activating research incubators and accelerators in cooperation with scientific facilities to accelerate the transformation of ideas into innovations.

It is worth It is noteworthy that the National Institute for Health Research has a public legal personality and financial and administrative independence, and is organizationally linked to the Minister of Health, and is headquartered in the city of Riyadh. The new organization represents a pivotal step in building an integrated system for health research and development in the Kingdom, which strengthens its position as a leading regional center in medical research and clinical trials, and supports its directions towards achieving a healthy society and sustainable national knowledge.

Axes Strategy

The strategic objectives of the National Institute for Health Research are defined in four main axes:

  • Improving health: contributing to raising the level of human health, well-being, and quality of life.
  • Finance and quality assurance: supporting and funding health research and ensuring the efficiency and quality of its outputs.
  • Transforming results into benefits: investing in results Research to achieve sustainable health and economic benefits.
  • Uniting efforts: coordinating and integrating the efforts of agencies working in the field of translational research and clinical trials.

Related Articles

Back to top button